Harbor Capital Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Harbor Capital Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Buy	+114,926	New	+$605K	0.04%	485

Other funds holding SRTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Harbor Capital Advisors's SRTA Position: Q2 2026 in Review

Harbor Capital Advisors opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 114,926 shares worth $606K. The stake represents 0.04% of the portfolio and ranks #485 among its holdings.

59 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

Harbor Capital Advisors held 114,926 shares of Strata Critical Medical Inc worth $606K as of Q2 2026.
Strata Critical Medical Inc was a new Harbor Capital Advisors position in Q2 2026.
Strata Critical Medical Inc made up 0.04% of Harbor Capital Advisors's portfolio in Q2 2026, its #485 holding.
59 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.